Endovascular treatment for superior vena cava obstruction in Behçet disease

Area of Science:

• Vascular Medicine
• Rheumatology
• Interventional Cardiology

Background:

• Behçet disease is a multisystem inflammatory disorder with frequent vascular involvement, primarily affecting veins.
• Superior vena cava (SVC) involvement is a rare but serious complication, occurring in only 6% of affected patients.
• SVC syndrome can lead to life-threatening complications due to venous obstruction.

Observation:

• A young male patient with Behçet disease presented with severe SVC syndrome.
• The patient's condition was critical, necessitating urgent intervention.
• Standard treatments were considered, but a novel approach was pursued.

Findings:

• Successful recanalization of the occluded SVC was achieved.
• The treatment involved a combination of fibrinolysis to dissolve the clot and self-expanding stents to maintain vessel patency.
• This minimally invasive approach resolved the life-threatening SVC syndrome.

Implications:

• This case demonstrates the efficacy of fibrinolysis and self-expanding stents in managing SVC syndrome secondary to Behçet disease.
• The findings suggest a potential therapeutic strategy for similar rare vascular complications in Behçet disease.
• Interventional techniques can offer life-saving solutions for complex vascular manifestations of systemic inflammatory disorders.